Publicacións en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (26)

2017

  1. Prevención, diagnóstico y tratamiento de la obesidad. Posicionamiento de la Sociedad Española para el Estudio de la Obesidad de 2016

    Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 15-22

2016

  1. Short-Term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus

    Nutrition and Diabetes, Vol. 6, Núm. 9, pp. e230

2006

  1. Effect of obesity and morbid obesity on the growth hormone (GH) secretion elicited by the combined GHRH + GHRP-6 test

    Clinical Endocrinology, Vol. 64, Núm. 6, pp. 667-671

  2. Efficacy of lanreotide Autogel® administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: A phase III trial

    Clinical Endocrinology, Vol. 65, Núm. 3, pp. 320-326

2005

  1. Erratum: Hypopituitarism following traumatic brain injury (TBI): A guideline Decalogue (Journal of Endocrinological Investigation (2004) 27, 8 (793))

    Journal of Endocrinological Investigation

  2. Prevalence of hypopituitarism and growth hormone deficiency in adults long-term after severe traumatic brain injury

    Clinical Endocrinology, Vol. 62, Núm. 5, pp. 525-532

  3. Traumatic brain injury as a relevant cause of growth hormone deficiency in adults: A KIMS-based study

    Archives of Physical Medicine and Rehabilitation, Vol. 86, Núm. 3, pp. 463-468

2004

  1. Growth hormone (GH) peaks versus areas under the curve in the diagnosis of adult GH deficiency: Analysis of the variables provided by the GHRH + GHRP-6 test

    Pituitary, Vol. 7, Núm. 1, pp. 15-20

  2. Hypopituitarism following traumatic brain injury (TBI): A guideline decalogue

    Journal of Endocrinological Investigation, Vol. 27, Núm. 8, pp. 793-795

2003

  1. Mechanisms underlying the neuroendocrine response to physical exercise

    Journal of Endocrinological Investigation, Vol. 26, Núm. 9, pp. 879-885

  2. Preoperative lanreotide treatment for GH-secreting pituitary adenomas: Effect on tumour volume and predictive factors of significant tumour shrinkage

    Clinical Endocrinology, Vol. 58, Núm. 4, pp. 471-481

2002

  1. A single growth hormone (GH) determination is sufficient for the diagnosis of GH-deficiency in adult patients using the growth hormone releasing hormone plus growth hormone releasing peptide-6 test

    Clinical Endocrinology, Vol. 57, Núm. 3, pp. 377-384

  2. Diagnóstico del déficit de hormona del crecimiento en pacientes adultos

    Endocrinologia y Nutricion

  3. Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome

    Clinical Endocrinology, Vol. 57, Núm. 6, pp. 745-749

  4. Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses

    Neuroendocrinology, Vol. 76, Núm. 6, pp. 390-396

2001

  1. Influence of cortisol status on leptin secretion

    Pituitary, Vol. 4, Núm. 1-2, pp. 111-116

1999

  1. Regulation of growth hormone secretion by signals produced by the adipose tissue

    Journal of Endocrinological Investigation, Vol. 22, Núm. 5 SUPPL., pp. 22-26

  2. The growth hormone (GH)-releasing hormone - GH - insulin-like growth factor-1 axis in patients with fibromyalgia syndrome

    Journal of Clinical Endocrinology and Metabolism, Vol. 84, Núm. 9, pp. 3378-3381

1998

  1. Serum leptin levels in male marathon athletes before and after the marathon run

    Journal of Clinical Endocrinology and Metabolism, Vol. 83, Núm. 7, pp. 2376-2379

  2. Theoretical considerations in estimating the growth hormone axis in adults

    Growth Hormone and IGF Research, Vol. 8, Núm. SUPPL. 2, pp. 93-96